London’s AIM All Share drifted lower throughout Thursday’s session, but losses were limited, with the index finishing down by less than two points at 736.66. This tracked a weak start on Wall Street and marked a notable underperformance when compared to other European indices.
- Brand Architekts +95%
- tinybuild +43%
- Quadrise +21%
- Gfinity -20%
- Oxford Biodynamics -20%
Brand Architekts LON:BAR added 95% on the day, making for the biggest gainer by some considerable margin. That comes on the back of news that Warpaint London had tabled an all cash offer for the business of 48p per share, a 100% premium to last night’s closing price. 31% of the target company’s shareholding has already agreed to the deal.
tinybuild LON:TBLD was up 43% in second place. There is however no news here but volumes were elevated with heavy buying demand noted.
- AIM Market Roundup: Blue Star Capital, Trellus Health, Distil
- Small Cap Stocks: Empyrean, Beacon Energy, Bushveld Minerals
Quadrise [LON:QED] added 21% to take the notable mention, following release of a product development update. Positive engine testing results have been received for a new biofuel, providing the company with a valuable boost in becoming a transition technology partner as businesses attempt to decarbonise. (We covered Quadrise’s deal with Auramarine last week.)
- Small Cap Stocks: Borders & Southern, GENIP, Smarttech 247
- Quadrise shares up over 300% in two-months
Gfinity LON:GFIN was at the foot of the table, down 20%, although that comes off the back of some significant gains which were posted on Wednesday. There’s no news to explain the price action.
- Small Cap Stocks: Capital Metals, Seascape Energy, Oracle Power
- Small Cap Stocks: Aquis, Gfinity, Team Internet
Oxford Biodynamics LON:OBD was in second to last place, falling just a shade less than 20% and making it into the column for a third successive day. Significant gains were posted on Tuesday and management responded after the close with a note that some may have seen as resolving cash issues. With no further progress on this front, the stock is under pressure and is now trading down on the week.
